Sonovia Aims to Make your Bedroom Safer for Sleep
A person’s bed linen can retain 17,000 times more bacteria than an average toilet seat within one week of use. That’s a frightening statistic, considering
Betalin Therapeutics chosen as 1 of top 5 Top Stem Cell Startups in the World!
After Startup Insights, a worldwide operating data science company headquartered in Austria, https://www.startus-insights.com/ analyzed 120 stem cell startups from around the world impacting the healthcare
Mirror Biologics Inc. Initiates AlloStim® Phase IIB Clinical Trial for Metastatic Colorectal Cancer
Mirror Biologics, Inc., a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ cancer vaccines in which
RenalSense Partners with Medline on Clarity RMS
Jerusalem based RenalSense Ltd., a privately-held medical device company and developer of Clarity RMS™, and Medline Industries, Inc., a leading global healthcare manufacturer and distributor,
VizibleZone Provides COVID-19 Exposure Notification Solution to the Israeli National Water Company
Jerusalem-based Artificial Intelligence (AI) startup VizibleZone today announced a deal with Mekorot, Israel’s National Water Company, to use VizibleZone‘s high accuracy exposure notification technology in
VOTIS Subdermal Imaging Raises US$2.5 Million
Jerusalem based VOTIS Subdermal Imaging Technologies, Ltd. has raised US$2.5 million in a private placement of equity to a consortium of investors in Israel, Italy,
Memorial Hermann Health System Former President & CEO, Dan Wolterman, appointed BactoByte Chair
BactoByte has appointed Mr. Dan Wolterman, Former President and CEO of Memorial Hermann Health System, as a Board Chair. With more than 40 years of
Respinova Granted FDA 510(k) Clearance for Pulsehaler
Respinova has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Pulsehaler™. Pulsehaler™ is an innovative device that facilitates the opening
KAHR’s Anti-CD47 in Blood Cancers Clinical Trials Funded by Texas MD Anderson Cancer Focus Fund
KAHR, a Jerusalem based clinical-stage cancer immunotherapy company developing novel bi-functional fusion proteins, and Cancer Focus Fund, LP, a unique venture capital fund established in
